Adnexal Mass

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lantheus Medical Imaging
1 program
1
Perflutren Lipid MicrospheresPhase 11 trial
Active Trials
NCT03297112CompletedEst. Sep 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Lantheus Medical ImagingPerflutren Lipid Microspheres

Clinical Trials (1)

NCT03297112Lantheus Medical ImagingPerflutren Lipid Microspheres

Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery

Start: Aug 2017Est. completion: Sep 2018
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space